Pharmacy Technician Certification Exam Practice Question
Upon review of a patient's drug profile, which combination may be considered duplication therapy?
Correct Answer: B
Rationale: Duplication therapy occurs when two medications serve the same therapeutic purpose, potentially increasing the risk of side effects without added benefit.
Option B, cetirizine and loratadine, both belong to the antihistamine class and are used to treat allergies, making them duplicative.
Option A involves hydralazine, an antihypertensive, and loratadine, an antihistamine, which serve different purposes.
Option C combines famotidine, a gastric acid reducer, with cetirizine, an antihistamine, also not duplicative as they target different conditions.
Option D includes hydralazine and famotidine, which address hypertension and gastric issues, respectively, and do not overlap in function.
Unlock All Questions
Subscribe to Premium for full access to all practice questions, detailed rationales, and performance tracking.
Subscribe Now